Ming Yan is CHIEF TECHNOLOGY OFFICER of Cytek Biosciences, Inc.. Currently has a direct ownership of 6.02 Million shares of CTKB, which is worth approximately $36.9 Million. The most recent transaction as insider was on Nov 18, 2024, when has been sold 3,622 shares (Common Stock) at a price of $6.03 per share, resulting in proceeds of $21,840. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.02M
0.19% 3M change
22.47% 12M change
Total Value Held $36.9 Million

Ming Yan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 18 2024
SELL
Payment of exercise price or tax liability
$21,840 $6.03 p/Share
3,622 Reduced 0.06%
6,018,322 Common Stock
Nov 18 2024
BUY
Exercise of conversion of derivative security
-
14,869 Added 0.25%
6,019,668 Common Stock
Aug 19 2024
SELL
Payment of exercise price or tax liability
$20,632 $5.53 p/Share
3,731 Reduced 0.06%
6,007,075 Common Stock
Aug 19 2024
BUY
Exercise of conversion of derivative security
-
14,869 Added 0.25%
6,008,421 Common Stock
May 20 2024
SELL
Payment of exercise price or tax liability
$18,696 $5.96 p/Share
3,137 Reduced 0.05%
5,995,937 Common Stock
May 20 2024
BUY
Exercise of conversion of derivative security
-
10,572 Added 0.18%
5,997,030 Common Stock
Apr 19 2024
SELL
Open market or private sale
$117,400 $5.87 p/Share
20,000 Reduced 0.33%
5,988,502 Common Stock
Apr 09 2024
SELL
Open market or private sale
$13,319 $7.01 p/Share
1,900 Reduced 0.03%
6,008,502 Common Stock
Mar 19 2024
SELL
Open market or private sale
$134,200 $6.71 p/Share
20,000 Reduced 0.33%
6,010,402 Common Stock
Mar 18 2024
SELL
Open market or private sale
$135,400 $6.77 p/Share
20,000 Reduced 0.33%
6,030,402 Common Stock
Mar 11 2024
SELL
Payment of exercise price or tax liability
$21,017 $7.22 p/Share
2,911 Reduced 0.05%
6,050,402 Common Stock
Mar 11 2024
BUY
Exercise of conversion of derivative security
-
9,817 Added 0.16%
6,053,313 Common Stock
Feb 20 2024
SELL
Payment of exercise price or tax liability
$4,927 $8.38 p/Share
588 Reduced 0.01%
6,043,496 Common Stock
Feb 20 2024
BUY
Exercise of conversion of derivative security
-
1,981 Added 0.03%
6,044,084 Common Stock
Dec 19 2023
SELL
Open market or private sale
$188,600 $9.43 p/Share
20,000 Reduced 0.33%
6,042,103 Common Stock
Nov 20 2023
SELL
Open market or private sale
$120,600 $6.03 p/Share
20,000 Reduced 0.26%
7,762,103 Common Stock
Nov 18 2023
SELL
Payment of exercise price or tax liability
$19,153 $5.98 p/Share
3,203 Reduced 0.04%
7,782,103 Common Stock
Nov 18 2023
BUY
Exercise of conversion of derivative security
-
9,344 Added 0.12%
7,784,534 Common Stock
Nov 14 2023
SELL
Bona fide gift
-
1,700,000 Reduced 21.9%
6,062,103 Common Stock
Oct 19 2023
SELL
Open market or private sale
$96,000 $4.8 p/Share
20,000 Reduced 0.26%
7,775,962 Common Stock
Sep 19 2023
SELL
Open market or private sale
$129,800 $6.49 p/Share
20,000 Reduced 0.26%
7,795,962 Common Stock
Aug 21 2023
SELL
Open market or private sale
$161,400 $8.07 p/Share
20,000 Reduced 0.26%
7,815,962 Common Stock
Aug 18 2023
SELL
Payment of exercise price or tax liability
$30,794 $8.46 p/Share
3,640 Reduced 0.05%
7,835,962 Common Stock
Aug 18 2023
BUY
Exercise of conversion of derivative security
-
9,344 Added 0.12%
7,838,830 Common Stock
Jul 19 2023
SELL
Open market or private sale
$175,200 $8.76 p/Share
20,000 Reduced 0.25%
7,830,258 Common Stock
MY

Ming Yan

CHIEF TECHNOLOGY OFFICER
Fremont, CA

Track Institutional and Insider Activities on CTKB

Follow Cytek Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTKB shares.

Notify only if

Insider Trading

Get notified when an Cytek Biosciences, Inc. insider buys or sells CTKB shares.

Notify only if

News

Receive news related to Cytek Biosciences, Inc.

Track Activities on CTKB